NASDAQ:VRNA
Delisted

Verona Pharma Stock Signals

etoro logo Buy VRNA
*Your capital is at risk
$106.91
+0 (+0%)
At Close: Jan 06, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Verona Pharma plc

General

Signal Type Signal Value Data
Score 0.000 179 days ( -72.41 %
Last Price $106.91 0 %
Performance History
7 Days
$106.91 $106.91
0%
30 Days
$106.91 $106.91
0%
12 Mos
$44.81 $106.91
138.59%

4/18

Active Buy Signals

Specific Signals

Short Term
Net score: 25
Signal Type Signal Value Importance Data
High / Low N/A Very Low $106.91 - $106.91
Trend - 3 mos 0 % High Width: 0.00000000000016 %
Pred. range - 3 mos $106.91 - $106.91 Low 0 % - 0 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jan 05, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low Oct 17, 2025 - 55 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 31.89
Signal Type Signal Value Importance Data
Trend - 12 mos 98.11 % Very High Width: 30.07 %
Pred. range - 12 mos $204.91 - $266.52 High 91.67 % - 149.30 %
Short MA 12 mos Sell Very High Sep 18, 2025 - 76 days
Long MA 12 mos Sell Very High Nov 30, -0001 - N/A days
Short/Long MA 12 mos Sell Very High Nov 30, -0001 - N/A days
Pivot Long Sell Low Jan 05, 2026 - 2 days
RSI Long Pivot Signal Sell Low Oct 28, 2025 - 48 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT VERONA PHARMA PLC
Verona Pharma
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the ...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE